PUK11 COST-MINIMIZATION ANALYSIS- MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA) VS. ARANESP (DARBEPOETIN ALFA) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) WHO ARE NOT RECEIVING HAEMODIALYSIS, IN POLISH SETTING
Abstract
Authors
P Kawalec J Kuzma M Szkultecka-Debek M Russel-Szymczyk A Slizien-Debska J Malyszko M Durlik